Precision Oncology’s Messerschmidt Video Interview: Promising Times in Rare Cancers


Rare Disease Report interviews Chief Medical Officer Gerald Messerschmidt while at the American Society of Hematology Annual Meeting. Messerschmidt comments on the recent surge in FDA activity pertaining to rare cancer types.

To see Dr. Messerschmidt’s video interview, please click here.


Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.